A documentation error occurs. The team investigates, retrains employees, and closes the record. A few months later, a similar error appears in another batch.
For life sciences organizations, recurring quality problems can consume resources, interrupt operations, and raise questions about whether corrective actions are addressing the underlying issue. Each event may appear manageable on its own, while the pattern points to a weakness that deserves broader attention.
Preventing recurrence requires more than completing an investigation or meeting a closure deadline. It requires understanding why the problem occurred, choosing an action that addresses that cause, and gathering evidence that the action works under normal operating conditions.
Look Beyond the Individual Event
Investigations often begin with a specific incident: a missed signature, an equipment alarm, a process step performed incorrectly, or an incomplete record. That starting point is necessary, but the review should also consider relevant history.
Has a similar issue occurred with another product? Does it affect multiple shifts? Have previous investigations identified the same contributing factor?
Events may be related even when they have different descriptions or appear in different reporting categories. One record might identify a documentation error, while another describes a failure to follow a procedure. Both could involve an instruction that employees find difficult to interpret.
Reviewing related events together can help teams identify a pattern that would remain hidden in separate investigations. The purpose is to determine whether the available evidence supports an isolated occurrence or a broader process weakness.
EMMA International explores the importance of treating CAPAs as systemic quality signals in The 7 Most Common CAPA Mistakes Life Sciences Companies Make.
Examine What “Human Error” Actually Explains
An employee’s action may be part of an event, but identifying that action does not necessarily explain why it happened.
If someone selected the wrong material, the investigation should examine the conditions surrounding that selection. Were labels easy to distinguish? Were materials stored in adjacent locations? Did the procedure provide a clear verification step? Were interruptions or workload pressures involved?
These questions help teams evaluate whether the process makes the correct action clear and reliable.
For example, retraining may be appropriate when an employee lacks necessary knowledge. If two materials have nearly identical labels and are stored together, additional training alone may leave an important source of risk unresolved.
A useful investigation connects the observed error to evidence about the process, equipment, instructions, and working conditions.
Match the Corrective Action to the Cause
Corrective actions should follow from the investigation’s findings. When the connection is weak, teams can complete every assigned task while leaving the original problem largely unchanged.
A revised procedure may help when instructions are incomplete or ambiguous. An equipment modification may be needed when a mechanical condition contributes to the event. A workflow adjustment may be appropriate when a handoff repeatedly creates confusion.
For pharmaceutical manufacturers, FDA’s ICH Q10 Pharmaceutical Quality System guidance, particularly Section 3.2.2, describes a structured approach to investigations aimed at determining root cause, with the effort and documentation proportionate to risk. It also recommends evaluating the effectiveness of corrective and preventive actions.
In practice, teams should be able to explain how each proposed action addresses the identified cause or contributing factor. That explanation creates a stronger basis for deciding what to implement and how to evaluate the result.
Define Success Before Measuring It
An effectiveness check needs a clear question to answer. “Confirm the action worked” leaves too much room for interpretation.
Before monitoring begins, teams should define the evidence they need, the acceptance criteria, the review period, and the person responsible for the evaluation. Those choices should reflect the problem’s risk and how often the affected activity occurs.
Consider a revised batch record intended to reduce missed entries. An effectiveness review might examine completed records across relevant shifts, assess whether the targeted omissions recur, and confirm that employees understand the revised instructions.
The review also needs enough opportunities for the problem to occur. Thirty days without recurrence may provide limited evidence if the affected process ran only once during that period.
Clear criteria help teams make a defensible decision about effectiveness and recognize when more information is needed.
Distinguish Completed Tasks From Improved Performance
Updating a procedure, conducting training, or installing a control demonstrates that an action was implemented. Determining whether that action improved the process requires additional evidence.
For example, a training attendance record confirms participation. Observing employees perform the task and reviewing subsequent records can help establish whether the training addressed the problem.
Similarly, confirming that a new equipment alarm was installed does not establish whether operators respond appropriately or whether the alarm reliably detects the condition of concern.
Organizations should evaluate both implementation and performance. This helps prevent administrative completion from becoming the sole basis for closing a quality improvement effort.
For a broader look at connecting CAPA activities with ongoing improvement, read Building Sustainable CAPA Programs: Moving Beyond Compliance to Continuous Improvement.
Use Recurrence to Reassess the Original Conclusion
When an issue returns, teams should compare the new event with the earlier investigation and corrective action. The recurrence may indicate an incomplete root cause analysis, inconsistent implementation, an effectiveness check that missed important conditions, or a different cause producing a similar outcome.
That distinction matters. Automatically repeating the previous action can consume time without improving control.
Leadership should also review recurring issues alongside operational context, including production volume, staffing changes, maintenance history, and process complexity. These discussions can reveal where teams need additional resources or where a local problem warrants attention elsewhere in the organization.
Build a Quality System That Learns
Recurring problems provide information about how a quality system performs in practice. Organizations can use that information to improve investigations, strengthen controls, and make effectiveness checks more meaningful.
The goal is to establish a documented connection between the problem, its cause, the action taken, and the evidence of improvement. When that connection is clear, quality teams are better positioned to prevent repeat events and support reliable operations.
These practices also support the approach discussed in How to Build an Inspection-Ready Organization Year-Round, where quality and compliance are built into routine operations.
EMMA International helps life sciences organizations strengthen deviation investigations, CAPA programs, and quality system performance. If recurring quality issues are placing pressure on your operations, contact EMMA International to discuss how your organization can build a more effective approach.
